PLEURODESIS WITH POVIDONE-IODINE: OUR EXPERIENCE IN MALIGNANT PLEURAL EFFUSION

Dr. Dipak Kumar Bhattacharyya, Dr Ridip Mazumdar

Abstract


BACKGROUND: Malignant pleural effusion is a frequently encountered condition. One of the procedures to treat this condition is chemical pleurodesis.. Aim of the study is to evaluate efficacy and safety of povidine-iodine as an agent of chemical pleurodesis. 

METHOD: Records of  patients with malignant pleural effusion admitted in Assam Medical College and Hospital and treated by chemical pleurodesis using povidone-iodine in CTVS unit from January 2016 to December 2018 was reviewed and analyzed to document its efficacy and safety.

RESULTS: Total 30 patients had undergone povidone-iodine pleurodesis during this period. Overall success of the procedure was observed in 26 (86.67%) and the procedure failed in 4(13.33%). Complications noted were chest pain in 13.33% and fever in 6.67% patients.

CONCLUSIONS: Povidone-iodine is an effective and safe agent for chemical pleurodesis. It can be used to treat malignant pleural effusion.


Keywords


Chemical pleurodesis, pleural symphysis, povidone-iodine, malignant pleural effusion

Full Text:

PDF

References


Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988; 108: 345–349.

Steger V, Mika U, Toomes H, Walker T, Engel C, Kyriss T, Ziemer G, Friedel G. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg 2007;83:1940-5.

Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65:Suppl. 2,ii32–ii40.

Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 2006;54:1-9.

Adler RH, Sayek I. Treatment of malignant pleural effusion: a method using tube thoracosctomy and talc. Ann Thorac Surg. 1976;22:8–15.

Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56–64.

Kahrom H, Aghajanzadeh M, Asgari MR, Kahrom M. Efficacy and safety of povidone-iodine pleurodesis in malignant pleural effusions. Indian J Palliat Care 2017;23:53-6.

Olivares-Torres CA, Laniado-Laborin R, Chavez-Garcia C, Leon-Gastelum C, Reyes-Escamilla A, Light RW. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002; 122 : 581-3.

Agarwal R. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis. Lung Cancer 2007;55:253-4.

Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J. 1997;10:1907–13.

Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008;83:235-50).

Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology 2007;18:28-32.

Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977;63:695–702.

Martinez-Moragon E, Aparicio J, Sanchis J, Menendez R, Cruz Rogado M, Sanchis F. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration. 1998;65:108–13.

Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med 2009;15:380-7.

Muduly, DK, Deo SVS , Subi TS , Kallianpur AA , Shukla NK. An update in the management of malignant pleural effusion. Indian J Palliat Care 2011;17:98-103.

Light RW, Pleural effusions related to metastatic malignancies, in: R.W. Light (Ed.), Pleural Diseases, Lippincott, Williams and Wilkins, Philadelphia, 2001, pp. 121–124.

Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58(Suppl 2):ii29–38.

Brock RC. The use of silver nitrate in the production of aseptic obliterative pleuritis. Guys Hosp Rep. 1942;91:99-103.

Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology. 2001;6(3):181-5.

Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir Med.2006;100:2043–7.

Echavarria A, Pinzon V, Bares JP, Fernandez E. Intracavitary treatment of malignant pleural effusion with iodine- povidone. Rev Med Panama. 1991;16:69–74.

Brissaud, O., Desfrere, L., Mohsen, R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003; 88: F531–F533.

Caglayan B, Torun E, Turan D, Fidan A, Gemici C, Sarac G, Salepci B, Kiral N. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann Surg Oncol 2008;15:2594-9.

Neto JD, de Oliveira SF, Vianna SP, Terra RM. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions. Respirology 2010;15:115-8.

Agarwal R, Khan A, Aggarwal AN, Gupta D. Efficacy & safety of iodopovidone pleurodesis: a systematic review & meta-analysis Indian J Med Res. 2012 Mar; 135(3): 297–304.

Mohsen TA, Zeid AA, Meshref M, Tawfeek N, Redmond K, Ananiadou OG, Haj-Yahia S. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur. J. Cardiothorac. Surg.2011; 40:282-286.


Refbacks

  • There are currently no refbacks.